Variable Rate of Detection of Immunoglobulin Heavy Chain V-D-J Rearrangement by PCR: a Systematic Study of 41 B-Cell Non-Hodgkin's Lymphomas and Leukemias

References

• Tonegawa S. Somatic generation of antibody diversity. Nature 1983; 302: 575–581
   PubMed Web of Science ®Google Scholar
• Chien Y., Gascoigne N. R. J., Kavaler J., Lee N. E., Davis M. M. Somatic recombination in a murine T cell receptor gene. Nature 1984; 309: 322–326
   PubMed Web of Science ®Google Scholar
• Yamada M., Wasserman R., Reichard B. A., Shane S., Caton A. J., Rovera G. Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J. Exp. Med. 1991; 173: 395–407
   PubMed Web of Science ®Google Scholar
• Knowles I I, Pelicci P.-G., Dalla-Favera R. Immunoglobulin and T cell receptor beta chain gene DNA probes in the diagnosis and classification of human lymphoid malignancy. Molecular and Cellular Probes 1987; 1: 15–31
   PubMed Web of Science ®Google Scholar
• Mullis K. B., Faloona F. A. Specific synthesis of DNA in vitro via a polymerase-catalyzed reaction. Methods Enzymol 1987; 155: 335–350
   PubMed Web of Science ®Google Scholar
• Crescenzi M., Seto M., Herzig G. P., Weiss P. D., Griffith R. C., Korsmeyer S. J. Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc. Natl. Acad. Sci. USA 1988; 85: 4869–4873
   PubMed Web of Science ®Google Scholar
• Trainor K. J., Brisco M. J., Story C. J., Morley A. A. Monoclonality in B-lymphoproliferative disorders detected at the DNA level. Blood 1990; 75: 2220–2222
   PubMed Web of Science ®Google Scholar
• Deane M., Norton J. D. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias. Eur. J. Immunol 1990; 20: 2209–2217
   PubMed Web of Science ®Google Scholar
• Deane M., Norton J. D. Detection of immunoglobulin gene rearrangement in B lymphoid malignancies by polymerase chain reaction gene amplification. Br. J. Haematol. 1990; 74: 251–256
   PubMed Web of Science ®Google Scholar
• Brisco M. J., Tan L. W., Orsborn A. M., Morley A. A. Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br. J. Haematol 1990; 75: 163–167
   PubMed Web of Science ®Google Scholar
• Nizet Y., Martiat P., Vaerman J. L., Philippe M., Wildmann C., Staelens J. P., Cornu G., Ferrant A., Michaux J. L., Sokal G. Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome. Br. J. Haematol 1991; 79: 205–210
   PubMed Web of Science ®Google Scholar
• Liang R., Chan V., Chan T. K., Wong T., Chiu E., Todd D. Detection of immunoglobulin gene rearrangement in acute and chronic lymphoid malignancies of B-cell lineage by polymerase chain reaction gene amplification. Am. J. Hematoi 1991; 38: 189–193
   PubMed Web of Science ®Google Scholar
• Mc Carthy K. P., Sloane J. P., Wiedemann L. M. Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. J. Clin. Pathol. 1990; 43: 429–432
   PubMed Web of Science ®Google Scholar
• Yamada M., Wasserman R., Lange B., Reichard B. A., Womer R. B., Rovera G. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment. N. Engl. J. Med 1990; 323: 448–455
   PubMed Web of Science ®Google Scholar
• Yamada M., Hudson S., Tournay O., Bittenbender S., Shane S. S., Lange B., Tsujimoto Y., Caton A. J., Rovera G. Detection of minimal residual disease in hematopoietic malignancies of the B-cell lineage by using third-complemen tary-determining region (CDR-III)-specific probes. Proc. Natl. Acad. Sci. USA 1989; 86: 5123–5127
   PubMed Web of Science ®Google Scholar
• Jonsson O. G., Kitchens R. L., Scott F. C., Smith R. G. Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes. Blood 1990; 76: 2072–2079
   PubMed Web of Science ®Google Scholar
• Wan J. H., Trainor K. J., Brisco M. J., Morley A. A. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J. Clin. Pathol. 1990; 43: 888–890
   PubMed Web of Science ®Google Scholar
• Macintyre E., Auriol L., Amesland F., Loiseau P., Chen Z., Boumsell L., Galibert F., Sigaux F. Analysis of junctional diversity in the preferential V1-J1 rearrangement of fresh T-acute lymphoblastic leukemia cells by in vitro gene amplification and direct sequencing. Blood 1989; 74: 2053–2061
   PubMed Web of Science ®Google Scholar
• Macintyre E. A., Auriol L., Duparc N., Leverger G., Galibert F., Sigaux F. Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias. J. Clin. Invest. 1990; 86: 2125–2135
   PubMed Web of Science ®Google Scholar
• Campana D., Yokota S., Coustan-Smith E., Hansen-Hagge T. E., Janossy G., Bartram C. R. The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: A comparative study. Leukemia 1990; 4: 609–614
   PubMed Web of Science ®Google Scholar
• Mc Carthy K. P., Sloane J. P., Kabarowski J. H. S., Matutes E., Wiedemann L. M. The rapid detection of clonal T-cell proliferations in patients with lymphoid disorders. Am. J. Pathol. 1991; 138: 821–828
   PubMed Web of Science ®Google Scholar
• Broeren C. P. M., Verjans G. M. G., Van Eden W., Kusters J. G., Lenstra J. A., Logtenberg T. Conserved nucleotide sequences at the 5′ end of the T cell receptor variable genes facilitate polymerase chain reaction amplification. Eur. J. Immunol. 1991; 21: 569–575
   PubMed Web of Science ®Google Scholar
• Hansen-Hagge T. E., Yokota S., Bartram C. R. Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor chain sequences. Blood 1989; 74: 1762–1767
   PubMed Web of Science ®Google Scholar
• Yokota S., Hansen-Hagge T. E., Ludwig W.-D., Reiter A., Raghavachar A., Kleihauer E., Bartram C. R. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 1991; 11: 331–339
   Google Scholar
• Sheibani K., Tubbs R. R. Enzyme immunohistoche-mistry: Technical aspects. Sent. Diag. Pathol 1984; 1: 235–250
   PubMedGoogle Scholar
• Ben-Ezra J., Winberg C. D., Wu A., Sheibani K., Rappaport H. Concurrent presence of two clonal populations in small lymphocytic lymphoma of the lung. Hum. Pathol 1987; 18: 399–402
   PubMed Web of Science ®Google Scholar
• Wu A. M., Ben-Ezra J., Winberg C, Colombero A. M., Rappaport H. Analysis of antigen receptor gene rearrangements in ethanol and formaldehyde-fixed, paraffin-embedded specimens. Lab. Invest. 1990; 63: 107–114
   PubMed Web of Science ®Google Scholar
• Ravetch J. V., Siebenlist U., Korsmeyer S., Waldmann T., Leder P. Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes. Cell 1981; 27: 583–591
   PubMed Web of Science ®Google Scholar
• Pangalis G. A., Nathwani B. N., Rappaport H. Malignant lymphoma, well differentiated type: Its relationship with chronic lymphocytic leukemia and macroglobulinemia of Waldenstrom. Cancer 1977; 39: 999–1010
   PubMed Web of Science ®Google Scholar
• Hansmann M.-L., Stein H., Dallenbach F., Fellbaum C. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma): A variant of the B-cell derived nodular type. Am. J. Pathol. 1991; 138: 29–36
   PubMed Web of Science ®Google Scholar
• Coles F. B., Cartun R. W., Pastuszak W. T. Hodgkin's disease, lymphocytes-predominant type: Immuno-reactivity with B-cell antibodies. Mod. Pathol. 1988; 1: 274–278
   PubMed Web of Science ®Google Scholar
• Chittal S. M., Alard C., Rossi J., Saati T., Le Tourneau A., Diebold J., Delsol G. Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution. Am. J. Surg. Pathol. 1990; 14: 1024–1035
   PubMed Web of Science ®Google Scholar
• Sundeen J. T., Cossman J., Jaffe E. S. Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent “large cell lymphoma”-Histological progression or composite malignancy?. Am. J. Surg. Pathol. 1988; 12: 599–606
   PubMed Web of Science ®Google Scholar